TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT03588975: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Sponsor: Vericel Corporation · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 45 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$2,592,920

Rescue Site Savings

+$1,697,184

Unlock Full NCT03588975 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT03588975 Rescue Dossier →